Virtus ETF Advisers LLC Adaptimmune Therapeutics PLC Transaction History

Virtus ETF Advisers LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.33 - $2.28 $58,919 - $101,003	-44,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.73 - $4.06 $4,551 - $10,681	-2,631 Reduced 5.61%	44,300 $91,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $5.68 $1,466 - $2,379	-419 Reduced 0.88%	46,931 $176,000
Q3 2021 Nov 15, 2021	SELL	$3.44 - $6.37 $8,493 - $15,727	-2,469 Reduced 4.96%	47,350 $245,000
Q2 2021 Aug 10, 2021	SELL	$3.86 - $5.78 $90,393 - $135,356	-23,418 Reduced 31.98%	49,819 $212,000
Q1 2021 May 17, 2021	BUY	$4.9 - $6.83 $6,286 - $8,762	1,283 Added 1.78%	73,237 $389,000
Q4 2020 Feb 12, 2021	BUY	$4.0 - $9.2 $163,780 - $376,694	40,945 Added 132.04%	71,954 $388,000
Q3 2020 Nov 13, 2020	SELL	$7.66 - $10.78 $32,417 - $45,620	-4,232 Reduced 12.01%	31,009 $247,000
Q2 2020 Aug 05, 2020	BUY	$2.58 - $12.1 $90,921 - $426,416	35,241 New	35,241 $353,000
Q2 2019 Aug 13, 2019	SELL	$3.23 - $5.41 $163,615 - $274,043	-50,655 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$3.63 - $6.06 $27,471 - $45,862	-7,568 Reduced 13.0%	50,655 $218,000
Q4 2018 Feb 05, 2019	BUY	$3.76 - $14.16 $77,531 - $291,979	20,620 Added 54.84%	58,223 $335,000
Q3 2018 Nov 14, 2018	SELL	$8.27 - $13.56 $228,400 - $374,500	-27,618 Reduced 42.35%	37,603 $510,000
Q2 2018 Aug 10, 2018	BUY	$10.42 - $13.74 $679,602 - $896,136	65,221 New	65,221 $774,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $114M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.